<b>Background/Objectives</b>: Alzheimer's disease (AD) involves amyloid and tau pathology with neuroimmune dysregulation, and Yixin Yangshen Granules (YXYS) shows neuroprotective promise, though mechanisms remain unclear. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.